Open Angle Glaucoma Clinical Trials

A listing of Open Angle Glaucoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 18 clinical trials
A Phase 3b Study to Evaluate the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension

This study evaluates the duration of intraocular pressure (IOP)-lowering effect and safety of as needed administrations of Bimatoprost sustained release (SR) in participants with open-angle

pigmentary glaucoma
glaucoma
bimatoprost
intraocular pressure
pseudoexfoliation glaucoma
  • 426 views
  • 22 Oct, 2022
  • 101 locations
A Phase 3, Randomized, Multi-Regional, Double-Masked, Parallel-Group Trial Evaluating the Safety and Efficacy of NCX 470 0.1% vs. Latanoprost 0.005% in Subjects With Open-Angle Glaucoma or Ocular Hypertension (Denali) (Denali)

-angle glaucoma. Subjects will be randomized in a 1:1 ratio to NCX 470 0.1% or to latanoprost 0.005% to be administered to both eyes once daily in the evening for up to 12 months.

corrected visual acuity
latanoprost
glaucoma
ophthalmic solution
intraocular pressure
  • 1 views
  • 11 Oct, 2022
  • 1 location
A Prospective, Multicenter Clinical Trial Designed to Evaluate the Safety and Effectiveness of the ELIOS System to Reduce Intraocular Pressure in Patients With Primary Open-Angle Glaucoma Undergoing Cataract Surgery (ELTGTS)

Evaluation of the safety and effectiveness of the ELIOS System procedure to reduce intraocular pressure (IOP) in adult subjects with mild to moderate primary open-angle glaucoma (POAG

  • 6 views
  • 12 Oct, 2022
  • 18 locations
Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only in Patients With Mild to Moderate Primary Open-Angle Glaucoma (CATALYST)

device (Nova Eye, Inc.) to cataract surgery only in patients with mild to moderate, primary open angle glaucoma. Subjects will be followed for 12 months.

hypotensive
ocular hypotensive
intraocular pressure
primary open angle glaucoma
cataract
  • 0 views
  • 24 Oct, 2022
BREMEN Eye Drops Versus Combigan for Open-angle Glaucoma or Intraocular Hypertension

The purpose of this study is to evaluate the clinical efficacy of the BREMEN eye drops in the treatment of primary open-angle glaucoma or intraocular hypertension.

intraocular pressure
combigan
glaucoma
hypertension
  • 4 views
  • 04 Oct, 2022
  • 1 location
  • 0 views
  • 18 Oct, 2022
Multicentric Evaluation of Best Corrected Visual Acuity of the XEN Implant Versus Classic Trabeculectomy in Open Angle Glaucoma Subjects

Multicentric evaluation of best corrected visual acuity of the XEN implant versus classic trabeculectomy in open angle glaucoma subjects

  • 0 views
  • 13 Oct, 2022
  • 1 location
MINIject (MINI SO627) in Patients With Open Angle Glaucoma Using Single Operator Delivery Tool

The study will assess safety and performance in patients with open-angle glaucoma uncontrolled by topical hypotensive medications who had previously been implanted with a MINIject glaucoma

  • 0 views
  • 04 Oct, 2022
  • 2 locations
Vision Preservation and Restoration Following a 6 Month Trial of GlaucoCetin

the optic nerve cells. Open angle glaucoma patients will be randomized to receive either a placebo or the medical food for 6 months. We hope to learn if this medical food can improve the vision of our

antioxidant
intraocular pressure
ganglion
humphrey visual field
  • 37 views
  • 04 Oct, 2022
  • 1 location
Hydrus(R) Microstent New Enrollment Post-Approval Study

To evaluate the rate of Hydrus Microstent malposition and associated clinical sequelae occurring within 24 months post-operation. This trial is a prospective, non-randomized, multicenter, single arm, post approval study. Qualified subjects will undergo uncomplicated cataract surgery with placement of a monofocal intraocular lens (IOL), followed by implantation of the Hydrus …

hypotensive
brimonidine tartrate ophthalmic solution
cataract
  • 12 views
  • 04 Oct, 2022
  • 10 locations